SelSA-1, a novel HDAC inhibitor demonstrates enhanced chemotherapeutic potential by redox modulation

por Garg, Ayushi, Desai, Dhimant, Bhalla, Aman, Thakur, Shalu, Rastogi, Pulkit, Kaushal, Naveen
Publicado 2023

Comparison of iso-effective and cost-effective high-dose-rate brachytherapy treatment schedules in cervical cancer – regional cancer center experience

por Thakur, Purnima, Dogra, Ekta, Gupta, Manish, Negi, Rati Ram, Fotedar, Vikas, Thakur, Shalu, Sharma, Chitranjan
Publicado 2019